Skip to content

Effect of gen for ?Schizophrenic Patients Treated with drug

Comparison of COMT Gene Polymorphisms and Response to ?Treatment and incidence of Extrapyramidal Side Effects in ?Schizophrenic Patients Treated with Olanzapine and Risperidone

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT2017012520258N29
Enrollment
61
Registered
2017-02-10
Start date
2014-05-06
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Schizophrenia. Organic delusional [schizophrenia-like] disorder

Interventions

Intervention 1: Intervention group: We prescribe 2-12 milligram Risperidone daily. Intervention 2: Intervention group: We prescribe 5-25 milligram Olanzapine? daily.
Treatment - Drugs
Intervention group: We prescribe 2-12 milligram Risperidone daily.
Intervention group: We prescribe 5-25 milligram Olanzapine? daily.

Sponsors

Vice chancellor for research, Arak University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Inclusion criteria: schizophrenia with PANSS score more than 60; don’t use anti psychotic drug one week before; IQ more than 70; don’t use ?anti psychotic drug in 6 months ago; don’t use Electrocardiography Therapy in one month ago Exclusion criteria: psychiatric disorders in axis 1 and 2; Suicide and other plumbing; addiction in 6 ?months ago; severe drug side effects

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Response to treatment. Timepoint: after 8 week treatment. Method of measurement: PANSS form.;Extra pyramidal side effects ?. Timepoint: after 8 week treatment. Method of measurement: ESRS-A form.;Drugs side effects. Timepoint: after 8 week treatment. Method of measurement: Questionnaire.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr seyed Yousef Shahtaheri

Arak University of Medical Sciences

fa.farokhi@gmail.com+98 86 3222 2003

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026